Mostrando 8 resultados de: 8
Filtros aplicados
Área temáticas
Enfermedades(7)
Ginecología, obstetricia, pediatría, geriatría(4)
Farmacología y terapéutica(3)
Fisiología humana(3)
Medicina y salud(2)
Origen
scopus(8)
11-Oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-hydroxylase deficiency
ArticleAbstract: Context: Patients with 21-hydroxylase deficiency (21OHD) have long-term complications, resulting froPalabras claves:Autores:Avila N.A., Elman M.S., Mallappa A., Marko J., Merke D.P., Rao H., Richard J. Auchus, Tsodikov A., Turcu A.F.Fuentes:scopusA Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia
ArticleAbstract: Context: Patients with classic congenital adrenal hyperplasia (CAH) often require supraphysiologic gPalabras claves:adrenal hypertrophy, ATR-101, Clinical trial, Congenital adrenal hyperplasia, nevanimibeAutores:Chang A.Y., El-Maouche D., Joyal E.G., Lin V.H., Merke D.P., Mohideen P., Plaunt M.R., Richard J. Auchus, Turcu A.F., Vogiatzi M.G., Weintraub L.Fuentes:scopusCongenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society* clinical practice guideline
ArticleAbstract: Objective: To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency cliPalabras claves:Autores:Arlt W., Baskin L.S., Conway G.S., Merke D.P., Meyer-Bahlburg H.F.L., Miller W.L., Murad M.H., Oberfield S.E., Richard J. Auchus, Speiser P.W., White P.C.Fuentes:scopusCorrection to: Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies (The Journal of Clinical Endocrinology and Metabolism (2021) 106:11 (e4666-e4679) DOI: 10.1210/clinem/dgab438)
OtherAbstract: Table 2 contained an error in the listed dose. For cohort B, the dose was incorrectly listed as 200Palabras claves:Autores:Barnes C.N., Huang M., Imel E.A., Madu I.J., Merke D.P., Moriarty D., Nakhle S., Newfield R.S., Richard J. Auchus, Sarafoglou K., Vogiatzi M.G.Fuentes:scopusErratum: Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society clinical practice guideline (The Journal of Clinical Endocrinology and Metabolism (2018) 103:11 (4043-4088) DOI: 10.1210/jc.2018-01865)
OtherAbstract: The above-mentioned guideline by Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, MePalabras claves:Autores:Arlt W., Baskin L.S., Conway G.S., Merke D.P., Meyer-Bahlburg H.F.L., Miller W.L., Murad M.H., Oberfield S.E., Richard J. Auchus, Speiser P.W., White P.C.Fuentes:scopusExcess 11-Oxygenated Androgens in Women With Severe Insulin Resistance Are Mediated by Adrenal Insulin Receptor Signaling
ArticleAbstract: Context: Syndromes of severe insulin resistance (SIR) include insulin receptoropathy, in which all sPalabras claves:11-oxygenated androgens, hyperandrogenism, insulin receptor, Lipodystrophy, ovaries, severe insulin resistanceAutores:Abel B.S., Brown R.J., Jha S., Merke D.P., Richard J. Auchus, Turcu A.F., Walzer D.Fuentes:scopusResponse to letter to the editor: “Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society clinical practice guideline”
OtherAbstract:Palabras claves:Autores:Merke D.P., Miller W.L., Richard J. Auchus, Speiser P.W., White P.C.Fuentes:scopusTildacerfont in Adults with Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies
ArticleAbstract: Context: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD) is typically treatePalabras claves:17-hydroxyprogesterone, adrenocorticotropic hormone, androstenedione, Congenital adrenal hyperplasia, CRF-receptor antagonist, tildacerfontAutores:Barnes C.N., Huang M., Imel E.A., Madu I.J., Merke D.P., Moriarty D., Nakhle S., Newfield R.S., Richard J. Auchus, Sarafoglou K., Vogiatzi M.G.Fuentes:scopus